Henan company begins production on COVID-19 oral drug

By SHI BAOYIN and ZHENG CAIXIONG | chinadaily.com.cn | Updated: 2022-08-03 20:29
Share - WeChat
Henan Biotech Ltd officially started production of Azvudine, an anti-COVID-19 oral medicine, in Pingdingshan, Central China's Henan province, on Aug 2, 2022. [Photo provided to chinadaily.com.cn]

The production base, which covers an area of 32,000 square meters, will be able to annually produce more than 3 billion tablets in the upcoming years.

Currently the product specification is 1 milligram according to Zhu Guoshan, director of the company's production department.

Space has also been reserved in production workshops and lines for more equipment to further expand production to meet market demands in the future, Zhu said.

Wang Chaoyang, founder of the company, said his company would enhance quality management for medicines produced at his company in the months to come.

Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349